The uncertain relationship between obesity and prostate cancer: An Italian biopsy cohort analysis

European Journal of Surgical Oncology

Volumn 37, Issue 12, 2011, Pages 1025-1029

  De Nunzio, C ^a   Freedland, S J ^b   Miano, L ^a   Finazzi Agr, E ^c   Banez L ^b   Tubaro, A ^a  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b DUKE UNIVERSITY MEDICAL CENTER   (United States)

^c TOR VERGATA UNIVERSITY HOSPITAL   (Italy)

Author keywords

Body mass index; Gleason score; Needle biopsy; Obesity; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TESTOSTERONE;

ADULT; AGE; AGED; ARTICLE; BODY MASS; CANCER GRADING; CANCER RISK; DIGITAL RECTAL EXAMINATION; DISEASE ASSOCIATION; GLEASON SCORE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; OBESITY; PRIORITY JOURNAL; PROSTATE; PROSTATE BIOPSY; PROSTATE CANCER; PROSTATE VOLUME; PROTEIN BLOOD LEVEL; TESTOSTERONE BLOOD LEVEL; TRANSRECTAL ULTRASONOGRAPHY;

ADULT; AGED; AGED, 80 AND OVER; BIOPSY; BODY MASS INDEX; COHORT STUDIES; CONFOUNDING FACTORS (EPIDEMIOLOGY); HUMANS; ITALY; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; NEOPLASM GRADING; OBESITY; ODDS RATIO; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; TESTOSTERONE; TUMOR MARKERS, BIOLOGICAL;

EID: 80955149015     PISSN: 07487983     EISSN: 15322157     Source Type: Journal    
DOI: 10.1016/j.ejso.2011.09.036     Document Type: Article

References (21)

1. A. Jemal, R. Siegel, and E. Ward Cancer statistics CA Cancer J Clin 59 2009 225 249
2. A.M. Wolf, R.C. Wender, and R.B. Etzioni American Cancer Society Prostate Cancer Advisory Committee: American Cancer Society guideline for the early detection of prostate cancer: update CA Cancer J Clin 60 2 2010 70 98
3. A. Berghofer, T. Pischon, and T. Reinhold Obesity prevalence from a European perspective: a systematic review BMC Public Health 8 2008 200 210
4. W.C. Buschemeyer, and S.J. Freedland Obesity and prostate cancer: epidemiology and clinical implications Eur Urol 52 2007 331 343
5. M.A. Goldstraw, D. Besrani, P. Amoroso, and R.S. Kirby Is obesity a risk factor for prostate cancer? BJU Int 100 4 2007 726 728
6. S.J. Freedland, J. Wen, and M. Wuerstle Obesity is a significant risk factor for prostate cancer at the time of biopsy Urology 72 2008 1102 1105
7. S.J. Freedland, L.L. Banez, and L.L. Sun Obese men have higher-grade and larger tumors: an analysis of the duke prostate center database Prostate Cancer Prostatic Dis 12 2009 259 263
8. J. Jayachandran, L.L. Banez, and W.J. Aronson Obesity as a predictor of adverse outcome across black and white race: results from the Shared Equal Access Regional Cancer Hospital (SEARCH) Database Cancer 115 2009 5263 5271
9. C.L. Amling, R.H. Riffenburgh, and L. Sun Pathologic variables and recurrence rates as related to obesity and race in men with prostate cancer undergoing radical prostatectomy J Clin Oncol 22 2004 439 445
10. H. Isbarn, C. Jeldres, and L. Budaus Effect of body mass index on histopathologic parameters: results of large European contemporary consecutive open radical prostatectomy series Urology 73 2009 615 619
11. F.K. Chun, A. Briganti, and M. Graefen Body mass index does not improve the ability to predict biochemical recurrence after radical prostatectomy Eur J Cancer 43 2007 375 382
12. A. Gallina, P.I. Karakiewicz, and G.C. Hutterer Obesity does not predispose to more aggressive prostate cancer either at biopsy or radical prostatectomy in European men Int J Cancer 121 2007 791 795
13. S.J. Freedland, M.K. Terris, and J.C. Presti Jr. Obesity and biochemical outcome following radical prostatectomy for organ confined disease with negative surgical margins J Urol 172 2 2004 520 524
14. S.J. Freedland, and W.J. Aronson Obesity and prostate cancer Urology 65 3 2005 433 439
15. C. De Nunzio, A. Trucchi, and R. Miano The number of positive cores for HGPIN on initial biopsy is associated with prostate cancer on second biopsy J Urol 181 2009 1069 1074
16. I.M. Thompson, P.J. Goodman, and C.M. Tangen The influence of finasteride on the development of prostate cancer N Engl J Med 349 2003 215 224
17. G.L. Andriole, D.G. Bostwick, and O.W. Brawley Effect of dutasteride on the risk of prostate cancer N Engl J Med 362 2010 1192 1202
18. R. Serfling, M. Shulman, and G.L. Thompson Quantifying the impact of prostate volumes, number of biopsy cores and 5-alpha-reductase inhibitor therapy on the probability of prostate cancer detection using mathematical modelling J Urol 177 2007 2352 2356
19. J.C. Presti Jr., G.J. O'Dowd, and M.C. Miller Extended peripheral zone biopsy schemes increase cancer detection rates and minimize variance in prostate specific antigen and age related cancer rates: results of a community multi-practice study J Urol 169 2003 125 129
20. W. Wallstrom, A. Bjartell, and B. Gullberg A prospective Swedish study on body size, body composition, diabetes and prostate cancer risk Br J Cancer 100 2009 1799 1805
21. S.J. Freedland, E. Giovannucci, and E.A. Platz Are findings from studies of obesity and prostate cancer really in conflict? Cancer Causes Control 17 1 2006 5 9